Latest News

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Recurrent violence linked to substantially higher rates of mental disorders in post-conflict communities

  • Luck affects how we judge reckless actions

  • Motor skill deficiencies linked to autism severity, reseearch says

  • New ultrasound device may add in detecting risk for heart attack, stroke

  • Leaders call for expanded use of medications to combat opioid overdose epidemic

  • Take notes by hand for better long-term comprehension

  • Paying closer attention to attention

  • Small business owners not always worried about being treated fairly, researcher finds

  • Fruitfly study identifies brain circuit that drives daily cycles of rest, activity

  • New genetic brain disorder in humans discovered

  •